Found 10 matching trials
An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults
PHASE2The purpose of this study is to evaluate the long-term safety of anifroluma...
Safety and Tolerability of Intravenous Dose of MEDI-546 in Japanese Subjects With Systemic Lupus Erythematosus.
PHASE2The purpose of this study is to assess safety, tolerability, pharmacokineti...
Anifrolumab Treatment for 24 Weeks in Patients With Primary Sjögren's Syndrome
PHASE2The ANISE-II study is a randomized, double-blind, placebo-controlled phase ...
Location
University Medical Centre Groningen
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
PHASE2The purpose of this study is to evaluate the efficacy and safety of MEDI-54...
Anifrolumab Early Access Program
N/ATo provide early access (ie, before marketing authorisation) to anifrolumab...
Status
No Longer Available
Location
Multiple Locations
Anifrolumab Real-world Treatment Outcomes in Systemic Lupus Erythematosus
N/AThe Polish multicentre observational (non-interventional) study aiming to c...
Status
Active Not Recruiting
A Study to Assess the Pharmacokinetics and Safety of Single Doses of Anifrolumab in Healthy Subjects
PHASE1This is a Phase I, Randomized, Placebo-Controlled, Double-Blind Study to As...
Long-Term Organ Damage: Anifrolumab Versus Real-World Standard of Care in Adult Patients With Active Systemic Lupus Erythematosus
N/AThis is an External control arm study to generate evidence on the comparati...
A Study to Target the Type I IFN Receptor by Administrating Anifrolumab in RA Patients With a High IFN Signature (TarIFNiRA)
PHASE2A multicenter, randomised, double-blind, placebo-controlled Phase 2A/ proof...
Location
Medizinische Universität Graz, Klinische Abteilung für Rheumatologie und Immunologie
Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
PHASE3The purpose of this study is to evaluate the efficacy and safety of an intr...